Neoadjuvant chemotherapy in hormone receptor-positive/HER2-negative early breast cancer: When, why and what?
Rosalba Torrisi, Emilia Marrazzo, Elisa Agostinetto, Rita De Sanctis, Agnese Losurdo, Giovanna Masci, Corrado Tinterri, Armando Santoro
Topics & Concepts
TaxaneBreast cancerOncologyAnthracyclineChemotherapyPathologicalMedicineHER2 negativeHormone receptorInternal medicineSubtypingNeoadjuvant therapyCancerCancer researchMetastatic breast cancerProgramming languageComputer scienceBreast Cancer Treatment StudiesHER2/EGFR in Cancer ResearchBreast Lesions and Carcinomas